Conventional hemodialysis provides incomplete removal of the spectrum of uremic solutes that accumulate in kidney failure, particularly middle and large molecular weight compounds. The clinical relevance of middle molecule retention was established in the HEMO study (Eknoyan et al., New England Journal of Medicine, 2002), which found that high-flux dialysis reduced beta-2 microglobulin levels and was associated with a significant mortality benefit in a pre-specified secondary analysis of patients who had been on dialysis for more than 3.7 years.
ISN (International Society of Nephrology) has reviewed evidence supporting convective clearance techniques through its educational content and KDIGO Controversies Conferences on dialysis. The ESHOL trial (Maduell et al., Journal of the American Society of Nephrology, 2013) reported a significant 30 percent reduction in all-cause mortality with high-volume online hemodiafiltration (HDF) compared to conventional HD in 906 Spanish patients over three years, representing one of the largest survival benefits observed in a dialysis modality trial.
The TURKISH OL-HDF and CONTRAST trials provided additional prospective data on HDF versus HD, with mortality benefits observed in the subgroup of patients achieving the highest convection volumes in post hoc analyses. The CONVINCE trial (Peters et al., New England Journal of Medicine, 2023), designed as a definitive test with pre-specified high-volume HDF versus high-flux HD, provided prospective evidence regarding clinical benefits of convective-enhanced therapy in a multicenter European randomized controlled trial.
Medium cutoff (MCO) membrane technology, characterized in detail by Zickler et al. (Journal of the American Society of Nephrology, 2017), offers expanded middle molecule removal during conventional HD without requiring convective substitution fluid volumes. MCO membranes demonstrated superior removal of kappa and lambda free light chains, myoglobin, and prolactin compared to high-flux membranes in head-to-head studies, with an acceptable albumin loss profile.
The International Society of Nephrology has underscored the importance of water quality standards in convective therapies. The ISPD and EUDIAL guidelines on water treatment, referenced in ISN educational materials, define microbiological purity thresholds for online HDF substitution fluid production, addressing the risk of endotoxin exposure and pyrogenic reactions in patients receiving high-volume convective replacement fluid during hemodiafiltration sessions.
